{"id": "article-28058_0", "title": "Physiology, Pulmonary Vasoconstriction -- Introduction", "content": "Pulmonary vasoconstriction is a physiological phenomenon and mechanism in response to alveolar hypoxia or low oxygen partial pressures\u00a0in the pulmonary arterioles and,\u00a0to some extent, the pulmonary venules. Pulmonary vasoconstriction\u00a0redirects blood flow within the vasculature away from poorly ventilated\u00a0parts of the lungs\u00a0towards better-ventilated\u00a0portions.\u00a0Ventilation and perfusion (V/Q) matching\u00a0is a\u00a0physiological process that influences gas exchange in the lung, as the lung attempts to efficiently pair oxygenated (ventilated)\u00a0regions\u00a0with areas of sufficient blood supply (perfusion). In low-oxygen states,\u00a0pulmonary vessels constrict in an attempt to shunt\u00a0blood to better-ventilated regions of the lung. Poor\u00a0oxygen availability has profound and overarching systemic ramifications manifesting in a plethora of pathologies starting within the lungs itself. Maintaining correct and appropriate oxygen homeostasis is a critical component for systemic stability and functioning, and the process begins within the\u00a0pulmonary vasculature. While many details pertaining to\u00a0pulmonary vasoconstriction are not fully understood, the mechanism\u00a0involves the activity of ion channels as well as several molecular and chemical agents. [1] [2]", "contents": "Physiology, Pulmonary Vasoconstriction -- Introduction. Pulmonary vasoconstriction is a physiological phenomenon and mechanism in response to alveolar hypoxia or low oxygen partial pressures\u00a0in the pulmonary arterioles and,\u00a0to some extent, the pulmonary venules. Pulmonary vasoconstriction\u00a0redirects blood flow within the vasculature away from poorly ventilated\u00a0parts of the lungs\u00a0towards better-ventilated\u00a0portions.\u00a0Ventilation and perfusion (V/Q) matching\u00a0is a\u00a0physiological process that influences gas exchange in the lung, as the lung attempts to efficiently pair oxygenated (ventilated)\u00a0regions\u00a0with areas of sufficient blood supply (perfusion). In low-oxygen states,\u00a0pulmonary vessels constrict in an attempt to shunt\u00a0blood to better-ventilated regions of the lung. Poor\u00a0oxygen availability has profound and overarching systemic ramifications manifesting in a plethora of pathologies starting within the lungs itself. Maintaining correct and appropriate oxygen homeostasis is a critical component for systemic stability and functioning, and the process begins within the\u00a0pulmonary vasculature. While many details pertaining to\u00a0pulmonary vasoconstriction are not fully understood, the mechanism\u00a0involves the activity of ion channels as well as several molecular and chemical agents. [1] [2]"}
{"id": "article-28058_1", "title": "Physiology, Pulmonary Vasoconstriction -- Issues of Concern", "content": "Pulmonary vasoconstriction is a topic of concern as an inappropriate reflex can result in pulmonary hypertension. Chronic pulmonary hypertension may lead to sequelae of hypoxemia, right heart failure, and venous congestion.", "contents": "Physiology, Pulmonary Vasoconstriction -- Issues of Concern. Pulmonary vasoconstriction is a topic of concern as an inappropriate reflex can result in pulmonary hypertension. Chronic pulmonary hypertension may lead to sequelae of hypoxemia, right heart failure, and venous congestion."}
{"id": "article-28058_2", "title": "Physiology, Pulmonary Vasoconstriction -- Organ Systems Involved", "content": "Hypoxic pulmonary vasoconstriction is a pulmonary vasculature mechanism. However, inappropriate and chronic vasoconstriction can lead to pulmonary hypertension, which has systemic ramifications. Pulmonary hypertension increases the work of the heart. The right ventricle, which propels poorly oxygenated blood\u00a0into the pulmonary artery, works\u00a0harder to overcome the increasing\u00a0pressures in the pulmonary circuit, leading to right ventricular hypertrophy in most cases. The grim sequelae of pulmonary hypertension may lead\u00a0to the classic 'cor pulmonale' presentation in which right\u00a0heart failure leads to venous congestion. [3] [4]", "contents": "Physiology, Pulmonary Vasoconstriction -- Organ Systems Involved. Hypoxic pulmonary vasoconstriction is a pulmonary vasculature mechanism. However, inappropriate and chronic vasoconstriction can lead to pulmonary hypertension, which has systemic ramifications. Pulmonary hypertension increases the work of the heart. The right ventricle, which propels poorly oxygenated blood\u00a0into the pulmonary artery, works\u00a0harder to overcome the increasing\u00a0pressures in the pulmonary circuit, leading to right ventricular hypertrophy in most cases. The grim sequelae of pulmonary hypertension may lead\u00a0to the classic 'cor pulmonale' presentation in which right\u00a0heart failure leads to venous congestion. [3] [4]"}
{"id": "article-28058_3", "title": "Physiology, Pulmonary Vasoconstriction -- Mechanism", "content": "Hypoxic pulmonary vasoconstriction relies\u00a0on the appropriate functioning and response of the pulmonary vasculature in the presence of diminished oxygen availability. Approximately 250 million alveoli are present within each lung. Each one is a functional unit that serves to deliver inhaled oxygen from the atmosphere to the blood and expulsion\u00a0of carbon dioxide from the blood to the atmosphere. The alveoli interact with the pulmonary capillaries, allowing for gas exchange.", "contents": "Physiology, Pulmonary Vasoconstriction -- Mechanism. Hypoxic pulmonary vasoconstriction relies\u00a0on the appropriate functioning and response of the pulmonary vasculature in the presence of diminished oxygen availability. Approximately 250 million alveoli are present within each lung. Each one is a functional unit that serves to deliver inhaled oxygen from the atmosphere to the blood and expulsion\u00a0of carbon dioxide from the blood to the atmosphere. The alveoli interact with the pulmonary capillaries, allowing for gas exchange."}
{"id": "article-28058_4", "title": "Physiology, Pulmonary Vasoconstriction -- Mechanism -- Theories of the Vasoconstriction Reflex", "content": "The vasoconstriction reflex is triggered\u00a0in states of hypoxia. There are contrasting views as to the vascular structures that first detect hypoxia.\u00a0The classical understanding suggests that decreased oxygen levels are\u00a0initially detected\u00a0within the pulmonary artery, whereas a new concept postulates\u00a0that low oxygen levels are detected in the\u00a0alveoli. This latter concept further suggests that gap junctions throughout the pulmonary endothelium transmit signals to\u00a0the pulmonary arterioles, causing them to constrict.", "contents": "Physiology, Pulmonary Vasoconstriction -- Mechanism -- Theories of the Vasoconstriction Reflex. The vasoconstriction reflex is triggered\u00a0in states of hypoxia. There are contrasting views as to the vascular structures that first detect hypoxia.\u00a0The classical understanding suggests that decreased oxygen levels are\u00a0initially detected\u00a0within the pulmonary artery, whereas a new concept postulates\u00a0that low oxygen levels are detected in the\u00a0alveoli. This latter concept further suggests that gap junctions throughout the pulmonary endothelium transmit signals to\u00a0the pulmonary arterioles, causing them to constrict."}
{"id": "article-28058_5", "title": "Physiology, Pulmonary Vasoconstriction -- Mechanism -- Original Understanding of the Vasoconstriction Reflex", "content": "The original mechanism is thought\u00a0to involve voltage-gated potassium and calcium channels. These channels are\u00a0located\u00a0in the smooth muscle cells\u00a0of the pulmonary arteries and are very sensitive to low oxygen states. In addition to the critical roles\u00a0of potassium and calcium in hypoxic pulmonary vasoconstriction, there are indications that there could be other ion channels contributing to the mechanism. These ion channels are transient receptor potential vanilloid 4 (TRPV4) and transient receptor potential canonical 6 (TRPC). [2] [5] [6]", "contents": "Physiology, Pulmonary Vasoconstriction -- Mechanism -- Original Understanding of the Vasoconstriction Reflex. The original mechanism is thought\u00a0to involve voltage-gated potassium and calcium channels. These channels are\u00a0located\u00a0in the smooth muscle cells\u00a0of the pulmonary arteries and are very sensitive to low oxygen states. In addition to the critical roles\u00a0of potassium and calcium in hypoxic pulmonary vasoconstriction, there are indications that there could be other ion channels contributing to the mechanism. These ion channels are transient receptor potential vanilloid 4 (TRPV4) and transient receptor potential canonical 6 (TRPC). [2] [5] [6]"}
{"id": "article-28058_6", "title": "Physiology, Pulmonary Vasoconstriction -- Related Testing -- Echocardiography", "content": "Echocardiography\u00a0uses ultrasound to visualize\u00a0the four chambers of the heart and provides insight regarding\u00a0inappropriate internal pressures or hypertrophy. In addition to the size of the right atrium and ventricle, the echocardiogram evaluates right ventricular ejection fraction through the tricuspid annular plane systolic excursion (TAPSE), another important consideration\u00a0when\u00a0diagnosing\u00a0hypertension in the pulmonary\u00a0vasculature.", "contents": "Physiology, Pulmonary Vasoconstriction -- Related Testing -- Echocardiography. Echocardiography\u00a0uses ultrasound to visualize\u00a0the four chambers of the heart and provides insight regarding\u00a0inappropriate internal pressures or hypertrophy. In addition to the size of the right atrium and ventricle, the echocardiogram evaluates right ventricular ejection fraction through the tricuspid annular plane systolic excursion (TAPSE), another important consideration\u00a0when\u00a0diagnosing\u00a0hypertension in the pulmonary\u00a0vasculature."}
{"id": "article-28058_7", "title": "Physiology, Pulmonary Vasoconstriction -- Related Testing -- Right Heart Catheterization", "content": "If preliminary findings warrant further investigation, a cardiologist\u00a0will conduct a right heart catheterization to confirm the diagnosis. A right heart catheterization provides information regarding the mean pulmonary artery pressure, right atrial pressure, and pulmonary artery occlusion pressure. It\u00a0also\u00a0can provide empirical information that would be used\u00a0to calculate a transpulmonary gradient and pulmonary vascular resistance.", "contents": "Physiology, Pulmonary Vasoconstriction -- Related Testing -- Right Heart Catheterization. If preliminary findings warrant further investigation, a cardiologist\u00a0will conduct a right heart catheterization to confirm the diagnosis. A right heart catheterization provides information regarding the mean pulmonary artery pressure, right atrial pressure, and pulmonary artery occlusion pressure. It\u00a0also\u00a0can provide empirical information that would be used\u00a0to calculate a transpulmonary gradient and pulmonary vascular resistance."}
{"id": "article-28058_8", "title": "Physiology, Pulmonary Vasoconstriction -- Related Testing -- Different Variables and Calculations", "content": "In a healthy individual at rest, the mean pulmonary artery pressure (mPAP) is 14 +/- 3 mmHg while a resting (mPAP) of greater than 25 mmHg would meet the criteria for a diagnosis of pulmonary hypertension. Pulmonary artery occlusion pressure (PAOP) and mean pulmonary artery pressure (mPAP) are variables in the calculations for determining transpulmonary gradient and pulmonary vascular resistance. The equation to\u00a0calculate pulmonary vascular resistance: (mPAP-PAOP)/(CO). The equation to calculate the transpulmonary gradient: mPAP-PAOP. Pulmonary artery occlusion pressure\u00a0is one of the most sensitive findings of right heart catheterization.", "contents": "Physiology, Pulmonary Vasoconstriction -- Related Testing -- Different Variables and Calculations. In a healthy individual at rest, the mean pulmonary artery pressure (mPAP) is 14 +/- 3 mmHg while a resting (mPAP) of greater than 25 mmHg would meet the criteria for a diagnosis of pulmonary hypertension. Pulmonary artery occlusion pressure (PAOP) and mean pulmonary artery pressure (mPAP) are variables in the calculations for determining transpulmonary gradient and pulmonary vascular resistance. The equation to\u00a0calculate pulmonary vascular resistance: (mPAP-PAOP)/(CO). The equation to calculate the transpulmonary gradient: mPAP-PAOP. Pulmonary artery occlusion pressure\u00a0is one of the most sensitive findings of right heart catheterization."}
{"id": "article-28058_9", "title": "Physiology, Pulmonary Vasoconstriction -- Related Testing -- Additional Testing", "content": "Additional testing needs to be completed to rule out other disease processes that could contribute to pulmonary hypertension.\u00a0Potential etiologies of pulmonary hypertension include\u00a0connective tissue diseases, obstructive sleep apnea, embolism, and left heart failure, to name a few. These include spiral CT or ventilation-perfusion (VQ) scans to rule out the presence of thromboembolic activity within the lung's vasculature. Pulmonary function testing identifies and categorizes any intrinsic lung disease that may be contributing. High-resolution CT imaging can be helpful when ruling out pulmonary parenchymal disease. [7] [8]", "contents": "Physiology, Pulmonary Vasoconstriction -- Related Testing -- Additional Testing. Additional testing needs to be completed to rule out other disease processes that could contribute to pulmonary hypertension.\u00a0Potential etiologies of pulmonary hypertension include\u00a0connective tissue diseases, obstructive sleep apnea, embolism, and left heart failure, to name a few. These include spiral CT or ventilation-perfusion (VQ) scans to rule out the presence of thromboembolic activity within the lung's vasculature. Pulmonary function testing identifies and categorizes any intrinsic lung disease that may be contributing. High-resolution CT imaging can be helpful when ruling out pulmonary parenchymal disease. [7] [8]"}
{"id": "article-28058_10", "title": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Classification of Pulmonary Hypertension", "content": "The complete pathophysiology of pulmonary hypertension (PH) is not entirely understood. The current etiologies of pulmonary hypertension are stratified into five groups.", "contents": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Classification of Pulmonary Hypertension. The complete pathophysiology of pulmonary hypertension (PH) is not entirely understood. The current etiologies of pulmonary hypertension are stratified into five groups."}
{"id": "article-28058_11", "title": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Classification of Pulmonary Hypertension", "content": "The first group is idiopathic PH, likely related to inheritable and intrinsic pulmonary arterial pathology.", "contents": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Classification of Pulmonary Hypertension. The first group is idiopathic PH, likely related to inheritable and intrinsic pulmonary arterial pathology."}
{"id": "article-28058_12", "title": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Classification of Pulmonary Hypertension", "content": "The second group is PH due to left heart disease, causing a build-up of volume and pressure\u00a0in the pulmonary vasculature.", "contents": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Classification of Pulmonary Hypertension. The second group is PH due to left heart disease, causing a build-up of volume and pressure\u00a0in the pulmonary vasculature."}
{"id": "article-28058_13", "title": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Classification of Pulmonary Hypertension", "content": "The third group is PH due to pathology within or related to the lungs. This group includes several different diseases such as COPD, sleep apnea, inflammatory scarring resulting from interstitial lung disease, chronic exposure to a high altitude environment, and certain developmental abnormalities.", "contents": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Classification of Pulmonary Hypertension. The third group is PH due to pathology within or related to the lungs. This group includes several different diseases such as COPD, sleep apnea, inflammatory scarring resulting from interstitial lung disease, chronic exposure to a high altitude environment, and certain developmental abnormalities."}
{"id": "article-28058_14", "title": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Classification of Pulmonary Hypertension", "content": "The fourth group is associated with frequent occurrence of embolic deposition in the lung's vessels or thrombosis known as chronic thromboembolic pulmonary hypertension (CTEPH).", "contents": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Classification of Pulmonary Hypertension. The fourth group is associated with frequent occurrence of embolic deposition in the lung's vessels or thrombosis known as chronic thromboembolic pulmonary hypertension (CTEPH)."}
{"id": "article-28058_15", "title": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Classification of Pulmonary Hypertension", "content": "The fifth group is designated for any remaining unclear or unestablished etiologies in addition to multifactorial causes. Examples of multifactorial processes that could contribute to or cause PH are metabolic disorders pertaining to the\u00a0thyroid, hematological disorders, and systemic pathologies that involve the respiratory system, such as sarcoidosis.", "contents": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Classification of Pulmonary Hypertension. The fifth group is designated for any remaining unclear or unestablished etiologies in addition to multifactorial causes. Examples of multifactorial processes that could contribute to or cause PH are metabolic disorders pertaining to the\u00a0thyroid, hematological disorders, and systemic pathologies that involve the respiratory system, such as sarcoidosis."}
{"id": "article-28058_16", "title": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Idiopathic Pulmonary Hypertension", "content": "Of these groups, idiopathic PH is the least understood. There are two prevailing concepts regarding the\u00a0progression of idiopathic PH. The most prevalent understanding is\u00a0related\u00a0to a\u00a0derangement in the production of local vasoconstrictors and dilators, denoted as the\u00a0vasoconstriction theory. The vasodilators include prostacyclin and nitric oxide, and the vasoconstrictors include thromboxane and endothelin. [3]", "contents": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Idiopathic Pulmonary Hypertension. Of these groups, idiopathic PH is the least understood. There are two prevailing concepts regarding the\u00a0progression of idiopathic PH. The most prevalent understanding is\u00a0related\u00a0to a\u00a0derangement in the production of local vasoconstrictors and dilators, denoted as the\u00a0vasoconstriction theory. The vasodilators include prostacyclin and nitric oxide, and the vasoconstrictors include thromboxane and endothelin. [3]"}
{"id": "article-28058_17", "title": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Roles of Chemical and Molecular Agents in Idiopathic Pulmonary Hypertension", "content": "In the vasoconstriction theory, nitric oxide (NO) plays a critical role in maintaining appropriate vascular tone. It is produced and regulated by two enzymes, nitric oxide synthase II and III. Patients with idiopathic pulmonary hypertension are found to have diminished levels of NO. Prostacyclin is a product of arachidonic acid metabolism. It is an effective vasodilator and exerts its effects on platelets as well. In patients experiencing pulmonary\u00a0remodeling, there are decreased levels of prostacyclin and the\u00a0enzyme prostacyclin synthase. On the contrary, endothelin 1, a systemic vasoconstrictor, is found in abnormally high quantities in idiopathic PH, which contradicts this theory. [9]", "contents": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Roles of Chemical and Molecular Agents in Idiopathic Pulmonary Hypertension. In the vasoconstriction theory, nitric oxide (NO) plays a critical role in maintaining appropriate vascular tone. It is produced and regulated by two enzymes, nitric oxide synthase II and III. Patients with idiopathic pulmonary hypertension are found to have diminished levels of NO. Prostacyclin is a product of arachidonic acid metabolism. It is an effective vasodilator and exerts its effects on platelets as well. In patients experiencing pulmonary\u00a0remodeling, there are decreased levels of prostacyclin and the\u00a0enzyme prostacyclin synthase. On the contrary, endothelin 1, a systemic vasoconstrictor, is found in abnormally high quantities in idiopathic PH, which contradicts this theory. [9]"}
{"id": "article-28058_18", "title": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Recent\u00a0Understanding of Idiopathic Pulmonary Hypertension", "content": "A\u00a0more recent understanding is centered on the concept of endothelial and smooth muscle cell activity in the context of arterial remodeling. Bone morphogenetic receptor type 2 (BMR2) is involved with cell growth, proliferation, and osteogenesis. It is believed that a mutation in BMR2 is directly involved in idiopathic PH. Another contributing factor may involve an\u00a0inappropriately high sensitivity to depolarization in vascular\u00a0smooth muscle cells. This alteration in the resting potential setpoint\u00a0may be\u00a0due to potassium channel irregularities that cause excess\u00a0availability of calcium. [10]", "contents": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Recent\u00a0Understanding of Idiopathic Pulmonary Hypertension. A\u00a0more recent understanding is centered on the concept of endothelial and smooth muscle cell activity in the context of arterial remodeling. Bone morphogenetic receptor type 2 (BMR2) is involved with cell growth, proliferation, and osteogenesis. It is believed that a mutation in BMR2 is directly involved in idiopathic PH. Another contributing factor may involve an\u00a0inappropriately high sensitivity to depolarization in vascular\u00a0smooth muscle cells. This alteration in the resting potential setpoint\u00a0may be\u00a0due to potassium channel irregularities that cause excess\u00a0availability of calcium. [10]"}
{"id": "article-28058_19", "title": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Sleep Apnea and Pulmonary Hypertension", "content": "A distinct relationship exists between obstructive sleep apnea (OSA) and the presence\u00a0of pulmonary hypertension (PH). OSA is not accepted as a\u00a0direct singular cause of PH; however, an association does exist. It is believed that OSA induces hypoxia during sleep, which creates a cycle of oxygen desaturation that\u00a0leads to decreased nitric oxide synthase, endothelin derangements, and an increase in\u00a0sympathetic tone. [11]", "contents": "Physiology, Pulmonary Vasoconstriction -- Pathophysiology -- Sleep Apnea and Pulmonary Hypertension. A distinct relationship exists between obstructive sleep apnea (OSA) and the presence\u00a0of pulmonary hypertension (PH). OSA is not accepted as a\u00a0direct singular cause of PH; however, an association does exist. It is believed that OSA induces hypoxia during sleep, which creates a cycle of oxygen desaturation that\u00a0leads to decreased nitric oxide synthase, endothelin derangements, and an increase in\u00a0sympathetic tone. [11]"}
{"id": "article-28058_20", "title": "Physiology, Pulmonary Vasoconstriction -- Clinical Significance -- Diagnosis", "content": "Hypoxic pulmonary vasoconstriction clinically manifests as pulmonary hypertension. To properly diagnose pulmonary hypertension, clinical criteria must be\u00a0met in the absence of a primary cause, and the degree of pulmonary hypertension must be determined. Early detection is paramount for\u00a0long-term morbidity and mortality. The initial process typically begins with an ECG and echocardiogram, followed by pulmonary function tests and cardiac catheterization.\u00a0Right heart pathology\u00a0such as\u00a0hypertrophy should be expected in chronic cases. [12] [13]", "contents": "Physiology, Pulmonary Vasoconstriction -- Clinical Significance -- Diagnosis. Hypoxic pulmonary vasoconstriction clinically manifests as pulmonary hypertension. To properly diagnose pulmonary hypertension, clinical criteria must be\u00a0met in the absence of a primary cause, and the degree of pulmonary hypertension must be determined. Early detection is paramount for\u00a0long-term morbidity and mortality. The initial process typically begins with an ECG and echocardiogram, followed by pulmonary function tests and cardiac catheterization.\u00a0Right heart pathology\u00a0such as\u00a0hypertrophy should be expected in chronic cases. [12] [13]"}
{"id": "article-28058_21", "title": "Physiology, Pulmonary Vasoconstriction -- Clinical Significance -- Nonsurgical Treatment", "content": "Therapy is\u00a0catered to the patient's individual profile. Pharmaceutical regimens are not always indicated for patients; however, anticoagulation is recommended for all diagnoses of idiopathic pulmonary hypertension if there are no contraindications. If pharmacological therapy is indicated, agents such as phosphodiesterase-5 inhibitors, calcium channel blockers,\u00a0prostacyclin analogs, endothelin receptor antagonists, and cyclic GMP agonists can be utilized. If pulmonary vasoconstriction is refractory to pharmacological therapy or if\u00a0the severity of the disease is extreme, surgery may\u00a0be a treatment option.\u00a0Patients with obstructive sleep apnea should be screened for pulmonary hypertension, and likewise, pulmonary hypertensive patients should be evaluated for sleep apnea due to the\u00a0association of both diseases. Continuous positive airway pressure (CPAP)\u00a0may treat OSA and concurrent pulmonary hypertension to a lesser degree.", "contents": "Physiology, Pulmonary Vasoconstriction -- Clinical Significance -- Nonsurgical Treatment. Therapy is\u00a0catered to the patient's individual profile. Pharmaceutical regimens are not always indicated for patients; however, anticoagulation is recommended for all diagnoses of idiopathic pulmonary hypertension if there are no contraindications. If pharmacological therapy is indicated, agents such as phosphodiesterase-5 inhibitors, calcium channel blockers,\u00a0prostacyclin analogs, endothelin receptor antagonists, and cyclic GMP agonists can be utilized. If pulmonary vasoconstriction is refractory to pharmacological therapy or if\u00a0the severity of the disease is extreme, surgery may\u00a0be a treatment option.\u00a0Patients with obstructive sleep apnea should be screened for pulmonary hypertension, and likewise, pulmonary hypertensive patients should be evaluated for sleep apnea due to the\u00a0association of both diseases. Continuous positive airway pressure (CPAP)\u00a0may treat OSA and concurrent pulmonary hypertension to a lesser degree."}
{"id": "article-28058_22", "title": "Physiology, Pulmonary Vasoconstriction -- Clinical Significance -- Surgical\u00a0Treatment", "content": "Surgical options include\u00a0atrial septostomy, which relieves right heart pressures via a right to left atrial shunt. Lung transplantation\u00a0may be\u00a0explored in severe cases. [14] [15]", "contents": "Physiology, Pulmonary Vasoconstriction -- Clinical Significance -- Surgical\u00a0Treatment. Surgical options include\u00a0atrial septostomy, which relieves right heart pressures via a right to left atrial shunt. Lung transplantation\u00a0may be\u00a0explored in severe cases. [14] [15]"}
{"id": "article-28058_23", "title": "Physiology, Pulmonary Vasoconstriction -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Physiology, Pulmonary Vasoconstriction -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}